OC
PVLA

Oppenheimer & Co’s Palvella Therapeutics PVLA Stock Holding History

Oppenheimer & Co’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-131
Closed -$1.74K – 1481
2023
Q2 		$1.74K Hold
131
– – ﹤0.01% 1411
2023
Q1 		$10.2K Hold
131
– – ﹤0.01% 1374
2022
Q4 		$10.9K Hold
131
– – ﹤0.01% 1343
2022
Q3 		$12K Hold
131
– – ﹤0.01% 1353
2022
Q2 		$20K Hold
131
– – ﹤0.01% 1387
2022
Q1 		$32K Buy
+131
New +$34.4K ﹤0.01% 1450
2021
Q3 		– Sell
-153
Closed -$47K – 1592
2021
Q2 		$47K Sell
153
-85
-36% -$18.6K ﹤0.01% 1488
2021
Q1 		$49K Hold
238
– – ﹤0.01% 1419
2020
Q4 		$48K Sell
238
-62
-21% -$12.9K ﹤0.01% 1330
2020
Q3 		$50K Sell
300
-10
-3% -$2.28K ﹤0.01% 1260
2020
Q2 		$77K Sell
310
-61
-16% -$14.3K ﹤0.01% 1217
2020
Q1 		$67K Buy
371
+62
+20% +$15.6K ﹤0.01% 1144
2019
Q4 		$89K Buy
+309
New +$85.7K ﹤0.01% 1246
2017
Q1 		– Sell
-206
Closed -$23K – 1358
2016
Q4 		$23K Buy
206
+18
+10% +$2.23K ﹤0.01% 1266
2016
Q3 		$27K Hold
188
– – ﹤0.01% 1251
2016
Q2 		$24K Sell
188
-558
-75% -$85.5K ﹤0.01% 1207
2016
Q1 		$113K Buy
746
+558
+297% +$78.5K ﹤0.01% 1170
2015
Q4 		$34K Buy
188
+63
+50% +$10.6K ﹤0.01% 1253
2015
Q3 		$18K Buy
+125
New +$27.9K ﹤0.01% 1333

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Oppenheimer & Co's PVLA Position: Q3 2023 in Review

Oppenheimer & Co sold out of Palvella Therapeutics (PVLA) in Q3 2023, closing a stake of 131 shares — an estimated $1.74K sold.

Oppenheimer & Co first reported a position in PVLA in Q3 2015 and held it in 19 quarters. The position peaked at $113K in Q1 2016. 43 funds tracked by Wall St. Rank hold PVLA as of Q3 2023.

  • Oppenheimer & Co reported no remaining Palvella Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Oppenheimer & Co sold 131 Palvella Therapeutics shares in Q3 2023, an estimated $1.74K.
  • Oppenheimer & Co first reported a position in Palvella Therapeutics in Q3 2015 and held it in 19 quarters.
  • Oppenheimer & Co's Palvella Therapeutics position peaked at $113K in Q1 2016.
  • 43 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2023.

Based on Oppenheimer & Co's 13F filing for Q3 2023, filed 8 Nov 2023.